SCHEMBL3295280

SCHEMBL3295280

CC(C)c1ccc(Nc2ccc(C3CCCCC3)cc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.48
EPHX1 P07099 2/20 0.48
EPHX2 P34913 2/20 0.48
LMNA P02545 2/20 0.48
TP53 P04637 2/20 0.48
NFKB1 P19838 2/20 0.48
RAB9A P51151 2/20 0.48
NPC1 O15118 1/20 0.48
HTT P42858 1/20 0.48
NFKB2 Q00653 1/20 0.48
RELA Q04206 1/20 0.48
CHEK2 O96017 1/20 0.43
ALDH1A1 P00352 3/20 0.43
MAPT P10636 2/20 0.43
ATM Q13315 1/20 0.43
APP P05067 1/20 0.43
HPGD P15428 1/20 0.42
GAA P10253 2/20 0.42
POLB P06746 1/20 0.42
NPY5R Q15761 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11213083 0.89 HPGD (0.50) SMN1; SMN2EPHX1EPHX2LMNATP53
SCHEMBL3300753 0.85 MAPT (0.50) SMN1; SMN2LMNATP53RAB9ANPC1
SCHEMBL11201092 0.85 MAPT (0.50) SMN1; SMN2LMNATP53RAB9ANPC1
SCHEMBL4820760 0.80 MAPT (0.62) SMN1; SMN2EPHX1LMNATP53RAB9A
SCHEMBL6352246 0.80 MAPT (0.49) SMN1; SMN2EPHX1LMNATP53RAB9A
SCHEMBL13769293 0.80 NPY5R (0.47) SMN1; SMN2LMNATP53RAB9ANPC1
SCHEMBL29196025 0.79 ESR2 (0.45) SMN1; SMN2LMNATP53RAB9AALDH1A1
SCHEMBL3295807 0.79 ALDH1A1 (0.50) EPHX1EPHX2LMNANFKB1CHEK2
SCHEMBL11199863 0.78 NPY5R (0.60) SMN1; SMN2LMNATP53RAB9AHTT
SCHEMBL1335958 0.78 NPY5R (0.60) SMN1; SMN2LMNATP53RAB9AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11584753-B2 Bisbenzofuran-fused 2,8-diaminoindeno[1,2-b]fluorene derivatives and related compounds as materials for organic electroluminescent devices (OLED) MERCK PATENT GMBH (DE) 2023-02-21 US disclosed
US-20180033965-A1 NOVEL DIAMINE COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME E-RAY OPTOELECTRONICS TECHNOLOGY CO., LTD. (TW) 2018-02-01 US disclosed
EP-1847525-B1 AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME IDEMITSU KOSAN CO (JP) 2010-12-15 EP disclosed
US-7834214-B2 Aromatic amine derivative and organic electroluminescence device employing the same IDEMITSU KOSAN CO., LTD. (JP) 2010-11-16 US disclosed
US-7737628-B2 Aromatic amine derivative and organic electroluminescence device using the same IDEMITSU KOSAN CO., LTD. (JP) 2010-06-15 US disclosed
US-20090058284-A1 AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2009-03-05 US disclosed
US-7470472-B2 Aromatic amine derivative and organic electroluminescence device employing the same IDEMITSU KOSAN CO., LTD. (JP) 2008-12-30 US disclosed
EP-1847525-A1 AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2007-10-24 EP disclosed
EP-1762562-A1 AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2007-03-14 EP disclosed
US-20060194074-A1 Aromatic amine derivative and organic electroluminescence device using the same IDEMITSU KOSAN CO., LTD. (JP) 2006-08-31 US disclosed
US-20060177693-A1 Aromatic amine derivative and organic electroluminescence device employing the same IDEMITSU KOSAN CO., LTD. (JP) 2006-08-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180033965-A1 NOVEL DIAMINE COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME OR10J3, AOC1, SAT1 SMN1; SMN2 2724/4885EPHX1 2251/4885EPHX2 2048/4885
US-20090058284-A1 AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME TYR, DDC, MAOA SMN1; SMN2 1959/4885EPHX1 547/4885EPHX2 379/4885
US-11584753-B2 Bisbenzofuran-fused 2,8-diaminoindeno[1,2-b]fluorene derivatives and related compounds as materials for organic electroluminescent devices (OLED) OCIAD1, OCIAD2, AOC1 SMN1; SMN2 3508/4885EPHX1 271/4885EPHX2 177/4885
US-20060194074-A1 Aromatic amine derivative and organic electroluminescence device using the same TYR, DDC, AOC2 SMN1; SMN2 2191/4885EPHX1 531/4885EPHX2 380/4885
US-20060177693-A1 Aromatic amine derivative and organic electroluminescence device employing the same TYR, DDC, MAOA SMN1; SMN2 1959/4885EPHX1 547/4885EPHX2 379/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.